. RALF4/19 form a tight complex with the LRR core of pollen LRX proteins. (A) Anti-HIS Western blot (left) of insect-cell culture pellets expressing or co-expressing RALF4, ANX1-RALF4 and LRX8-RALF4. SDS-PAGE of corresponding secreted protein fractions (right). (B) Schematic overview of LRX8 and LRX11 domains, including the amino acid coordinates according to structural data. (C) Analytical size exclusion chromatography (SEC) of LRX833-400-RALF4, LRX1145-415-RALF4, and LRX849-400-RALF19 complexes (left). SDS-PAGE (right) of the different peaks corresponding to the SEC experiments. (D) Mapping of the LRX8/LRX11 domain interacting with RALF4 according to the schematic diagram in (B). SEC (left) of the LRX8/11-RALF4 complexes. SDS-PAGE (right) of the different SEC peaks. Colors of the SEC plots and the corresponding peak legends are matching. (E) Grating-coupled interferometry (GCI)-derived binding kinetics for LRX8 vs RALF4folded. Shown are the sensogram with data in red and the respective curve fits in black. Table summaries of kinetic parameters are shown below (ka, association rate constant; kd, dissociation rate constant; KD, dissociation constant). (F) and (G) Isothermal titration calorimetry thermogram (ITC) of the LRX8 protein vs RALF4synthetic and RALF4C86A.C105A, respectively. Figure S2 . LRX8-RALF4 and LRX11-RALF4 mass spectrometry sequence determination. (A) and (B) Results from LC-MS/MS analysis of LRX8-RALF4 and LRX11-RALF4 protein complexes. Number of peptides and coverage for each component of the complex is highlighted in yellow. Oxidised methionines are highlighted in green. Leu 3 of LRX8 was identified as the Nterminal, N-acetylated residue, although the modification was only sporadically identified and was thus partial. Cys residues were reduced and alkylated (carbamidomethyl, not shown) and searched as fixed modification. All the sequence coverages are the combined results of tryptic and chymotryptic digestions and separate LC-MS/MS analyses on a high resolution orbitrap Fusion instrument. Samples in (A) were analysed by both HCD and EThcD fragmentation, while for results in (B) only HCD fragmentation was used. For more details see the Materials and Methods section. Circular dichroism near-UV spectra corresponding to different RALF4 peptides in solution. Depicted are the spectra for RALF4folded (blue), RALF4synthetic (red) and RALF4CCCC (green). Broad increase in signal (y-axes) indicates an increase in disulfide bonds abundance. Error bars represent the SEM over 10 measures. Molecular weight determination of the respective complexes using Multi Angle Light Scattering (MALS). UV280 absorption is plotted in purple, light scattering (LS) in orange, and the determined molecular weight (Da) in grey. The molecular weight indicated on each plot is the mean ± SD of two independent measurements. Structure-based sequence alignment of the LRX family members. The alignment includes a secondary structure assignment calculated with the program DSSP and colored according to Fig. 2 and Fig. S1B . Cys residues engaged in disulfide bonds are squared in red, with matching pairs indicated by numbers. Predicted and experimentally verified N-glycosylation sites are depicted by black stars. The various interaction surfaces in the LRX2/8-RALF4 complex structures are highlighted according to the following color code: LRX dimer interface in blue, LRX-RALF4 binding pocket in pink, and the interaction surface of the LRX Cys extension with the LRR core of the protein is highlighted in light orange. Figure S8 . RALF4 omit map and surface electrostatic potential of the peptide exposed surface.
LRX8
(A) RALF4 simulated annealing 2Fo-Fc omit electron density map contoured at 1.5 s. (B) RALF4 reveals a positively-charged surface when bound to LRX. Details of the basic nature of RALF4 exposed surface (left). Arg (R) and Lys (K) free residues are shown as sticks in light orange. Electrostatic surface representation of RALF4 when in complex with LRX2 (right). LRX2 is shown in grey and RALF4 solvent-accessible surface electrostatic potential has been calculated using APBS plugin (PyMOL). The potential is given with the negative (red) and positive (blue) contour levels in the range from -8.0 to +8.0 kBT, respectively. (A) Sequencing data of cDNA amplification of LRX8 in WT and lrx8, 9, 10, 11 complemented with either pLRX8::LRX8C157A.Y87A.A133F, pLRX8::LRX8Y87A.A133F or pLRX8::LRX8F109A.H150A, showing that the expression of the LRX8 band in (B) corresponds to the expression of the inserted mutant versions. (B) cDNA amplification of LRX8 in WT, lrx8, 9, 10, 11, and lrx8, 9, 10, 11 complemented by either pLRX8::LRX8C157A.Y87A.A133F, pLRX8::LRX8Y87A.A133F, or pLRX8::LRX8F109A.H150A, showing restoration of LRX8 expression in the complemented lines. (C) a-myc protein detection of LRX8 mutants in pollen. Introduction of the dominant active MRIR240C kinase does not suppress the pollen tube defects of lrx8/9/10/11 quadruple and lrx9/10/11 triple mutants, as evidenced by the strongly reduced seed set per silique. Mutants with or without the MRIR240C transgene (3 independent T1 lines) show no statistically significant (ns) difference in seed set. Six to eight siliques of three plants were analyzed per genotype. The plants marked by * were not grown at the same time (data from ref 5 ) but since the wild-type (wt) controls showed no statistically significant difference, they are shown in the same graph. The inlet shows that although MRIR240C-CFP was expressed in pollen grains and pollen tubes of the T1 plants, it did not suppress the lrx9/10/11 mutant phenotype. Scale bar, 10 µm. 
